Home 
How Blumble Works 
Search Algorithm 
Your Privacy 
About 
Facebook
Twitter
Blog
71
100
Aurobindo posted Ebitda of Rs 4,387 crore and a net profit of Rs 2,647 crore in FY22. In May 2021, Aurobindo Pharma approved the transfer of its injectable assets into Eugia Pharma Specialities Ltd for "greater focus, attention, and specialisation". The move was seen as a precursor to unlock value, raise funds and eventually list it.
- Safe
- United States
- Encrypted
- 28 yrs old
- 220 Site Rank
- Report Card
86
100
Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around ₹4,500 crore. "With the markets in a buoyant phase and pharma valuations looking attractive, Aurobindo Pharma is now evaluating a listing of Eugia. The deal was kicked off recently with all the advisors," said one of the persons. By Moneycontrol News January 10 ...
- Safe
- India
- Encrypted
- 21 yrs old
- 8,206 Site Rank
- Report Card
71
100
Aurobindo Pharma temporarily stops manufacturing at Eugia's Unit-III facility in Hyderabad after receiving 9 USFDA observations. The company is working to address the issues and resume ...
- Safe
- United States
- Encrypted
- 28 yrs old
- 220 Site Rank
- Report Card
80
100
Eugia's parent parent Aurobindo Pharma was founded in 1986 by P.V. Ramprasad Reddy, K. Nityananda Reddy and a small group of professionals. According to the firm's website, in addition to being a ...
- Safe
- United States
- Encrypted
- 25 yrs old
- 783 Site Rank
- Report Card
80
100
Aurobindo Pharma Ltd on Tuesday announced that its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for its generic version of Vasopressin ...
- Safe
- United States
- Encrypted
- 26 yrs old
- 2,701 Site Rank
- Report Card
WEBSITE REPORT CARD
-
![]()
Norton safe Web
-
McAfee Web Advisor
-
Site is
-
Hosted in
-
-
Traffic rank:
-
Site age:
-
Site Owner information
Norton safe Web